Cargando…

The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials

OBJECTIVE: Opioid use has reached an epidemic proportion in Canada and the United States that is mostly attributed to excess availability of prescribed opioids for pain. This excess in opioid use led to an increase in the prevalence of opioid use disorder (OUD) requiring treatment. The most common t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanger, Nitika, Panesar, Balpreet, Rosic, Tea, Dennis, Brittany, D'Elia, Alessia, Hillmer, Alannah, Chawar, Caroul, Naji, Leen, Hudson, Jacqueline, Samaan, M. Constantine, de Souza, Russell J., Marsh, David C., Thabane, Lehana, Samaan, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023161/ https://www.ncbi.nlm.nih.gov/pubmed/32556002 http://dx.doi.org/10.1590/1516-4446-2019-0734

Ejemplares similares

The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior
por: Panesar, Balpreet, et al.
Publicado: (2021)

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
por: Au, Vivian Y. O., et al.
Publicado: (2021)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
por: Shams, Ieta, et al.
Publicado: (2019)

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
por: Chawar, Caroul, et al.
Publicado: (2021)

GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
por: Chawar, Caroul, et al.
Publicado: (2020)

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Genetic basis of cannabis use: a systematic review
por: Hillmer, Alannah, et al.
Publicado: (2021)

The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review
por: Sanger, Nitika, et al.
Publicado: (2022)

Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol
por: D'Elia, Alessia, et al.
Publicado: (2021)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder
por: Naji, Leen, et al.
Publicado: (2021)

Genetic determinants of cannabis use: a systematic review protocol
por: Hillmer, Alannah, et al.
Publicado: (2020)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences
por: Chawar, Caroul, et al.
Publicado: (2021)

Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2021)

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences
por: Naji, Leen, et al.
Publicado: (2018)

Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study
por: Hillmer, Alannah, et al.
Publicado: (2023)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
por: van Reekum, Emma A., et al.
Publicado: (2021)

Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review
por: Rodrigues, Myanca, et al.
Publicado: (2021)

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
por: van Reekum, Emma A., et al.
Publicado: (2020)

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study
por: Rosic, Tea, et al.
Publicado: (2017)

Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy
por: Lamont, Rachel, et al.
Publicado: (2020)

Factors affecting participant recruitment and retention in borderline personality disorder research: a feasibility study
por: Woo, Julia, et al.
Publicado: (2021)

Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
por: Rosic, Tea, et al.
Publicado: (2020)

Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
por: Sanger, Nitika, et al.
Publicado: (2021)

Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol
por: Naji, Leen, et al.
Publicado: (2021)

A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder
por: Dennis, Brittany B., et al.
Publicado: (2020)

Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care
por: Sergeant, Anjali, et al.
Publicado: (2020)

Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study
por: Rosic, Tea, et al.
Publicado: (2021)

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder
por: Leung, Kelly, et al.
Publicado: (2021)

National suicide management guidelines recommending family-based prevention, intervention and postvention and their association with suicide mortality rates: systematic review
por: Panesar, Balpreet, et al.
Publicado: (2022)

Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2018)

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2018)

A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone
por: Naji, Leen, et al.
Publicado: (2016)

The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol
por: Dennis, Brittany Burns, et al.
Publicado: (2014)

The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy
por: Naji, Leen, et al.
Publicado: (2017)

National suicide management guidelines with family as an interv’ention and suicide mortality rates: a systematic review protocol
por: Panesar, Balpreet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mcia7tsr2ud2ae87rc2sn43783